#China #Shanghai #ZEISS #SMILE Pro #VISUMAX 800

ZEISS VISUMAX 800 with SMILE Pro Software Approved in China

ZEISS Medical Technology has today announced a significant development in the realm of ophthalmology. The National Medical Products Administration (NMPA) in China has granted approval for the VISUMAX® 800 laser system equipped with SMILE® Pro software. This cutting-edge technology is designed for the surgical correction of nearsightedness, including cases with astigmatism.

With this approval, ZEISS expands its reach in the Chinese market just as the global demand for laser vision correction continues to rise, particularly among the growing population of eye care patients across Asia, Europe, and the United States. To date, more than 10 million eyes have undergone treatment using ZEISS SMILE technology, a testament to its reliability and effectiveness in refractive surgery.

Addressing the Needs of Surgeons and Patients

According to Maximilian Foerst, Head of ZEISS Greater China, the introduction of the VISUMAX 800 is timely due to the increasing interest in laser vision correction procedures in China. He emphasized the importance of innovative technology that enhances surgical outcomes, safety, and efficiency, which ultimately benefits both surgeons and their patients in the operational workflow.

Magnus Reibenspiess, Head of the Strategic Business Unit Ophthalmology at ZEISS Medical Technology, highlighted how this new system not only complements the capabilities of refractive surgeons but also aligns with their evolving needs. The VISUMAX 800 with SMILE pro software boasts a range of advanced features that significantly enhance the surgical experience.

New Features and Enhancements

The VISUMAX® 800 is backed by advanced femtosecond laser technology that significantly speeds up the treatment process. One of the standout features of this system is its capability to create the lenticule in less than 10 seconds, thanks to its high laser pulse repetition rate of 2 MHz. This rapid processing not only improves workflow efficiency but also reduces stress for both patients and surgeons during procedures, making for a smoother surgical experience.

In addition, the smaller footprint of the VISUMAX 800 allows it to fit in a variety of clinical settings, maximizing its compatibility with different patient beds. It thus adjusts seamlessly to diverse surgical environments while ensuring that cutting-edge technology is always within reach.

The system introduces several workflow enhancements designed to optimize surgical procedures:

• - CentraLign® Centration Aid: A computer-controlled feature that simplifies the centration process for surgeons.
• - OcuLign® Cyclotorsion Adjustment: This feature addresses and compensates for cyclotorsion that can occur during surgery, enhancing precision.
• - VISULYZE User Nomograms: These allow surgeons to easily collect and analyze patient data, ensuring a tailored surgical approach.

These enhancements illustrate ZEISS's commitment to providing surgeons with not only innovative technology but also data-driven insights for optimal treatment management.

Future of Laser Vision Correction in China

The approval of the VISUMAX® 800 with SMILE pro software promises to create significant opportunities within the Chinese ophthalmic market. The increasing advancements and available features position this laser system as a pivotal tool for surgeons aiming to improve patient care while navigating the complexities of refractive surgery.

In summary, the launching of the VISUMAX 800 in China marks a new chapter in the realm of laser vision correction, paving the way for enhanced surgical precision, patient comfort, and overall efficiency in treatment processes. For more details about ZEISS's latest offerings, visit ZEISS website.

In this fast-evolving field, ZEISS remains a leader, bringing innovative solutions to meet the ever-changing demands of both eye care professionals and their patients.